Blog
Alphabet Q1 2020 Earnings Preview: What to Watch
Search giant Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) will report its earnings after the markets close on Tuesday, April 28. It will be the first time the technology giant will address shareholders
This Chip Stock Pays a Nice Dividend, but Should You Buy?
Analog Devices (NASDAQ: ADI) management seemed confident of the company's ability to withstand the novel coronavirus-related uncertainties a couple of months ago. It also sweetened its dividend with
Will COVID-19 Bring Social Security Closer to Insolvency?
Social Security is a critical income source for millions of retired seniors. But the program is facing some serious financial shortcomings that may force it to cut benefits in the not-so-distant
This High-Yield Dividend Is Still Safe Despite the Coronavirus
Speaking on the company' second-quarter earnings call, Emerson Electric Company (NYSE: EMR) CEO David Farr left investors in no doubt as to the depth of his commitment to maintaining Emerson's
Impinj Crushed Wall Street's Estimates in This Earnings Report Under COVID-19
Radio frequency identification (RFID) specialist Impinj (NASDAQ: PI) reported first-quarter results after the closing bell on Monday. Revenues rose 44% year over year while the bottom line swung to
Sunoco's 14% Yield: Too Good to Be True?
Fuel distributor Sunoco LP's (NYSE: SUN) latest payout to investors makes the yield on this master limited partnership, or MLP, a whopping 14%. Yields that high often make investors skeptical about
What to Do if You're Forced to Retire Early Due to COVID-19
The coronavirus pandemic has led to an unprecedented number of layoffs, with approximately 26 million workers filing for unemployment benefits over the last five weeks.
No matter your age or where
Carnival Stock: Buy, Sell, or Hold?
Will the cruise industry ever fully recover? That's a fair question to ask, but it's also one colored by the current situation where nothing feels normal.
The reality is that someday even COVID-19
Is American Express a Buy?
Last week, American Express (NYSE: AXP) reported its first-quarter earnings. Like many of the other big banks, the company reported a large provision for loan losses in the first quarter, as the
Why I'm Buying Warren Buffett's Highest-Yielding Dividend Stock Right Now
Warren Buffett loves dividends. Most stocks that he adds to the Berkshire Hathaway (NYSE: BRK.A) (NYSE: BRK.B) portfolio make regular cash payments to their shareholders. And right now, many of them
Quest Diagnostics Is Set to Ride Out Coronavirus Concerns
Despite recent layoffs and cutbacks, diagnostic testing giant Quest Diagnostics (NYSE: DGX) is a good long-term buy for investors looking for safety because it has been extending its already
3 Top Industrial Stocks to Buy Right Now
It's not shaping up to be a great year for the industrial sector, but that doesn't mean investors can't find industrial stocks to buy at attractive prices. There's no doubt that railroad Union
Twitter Earnings: What to Watch
Of the many tech companies reporting earnings this week, Twitter (NYSE: TWTR) will be one of the most interesting to watch. The company said in a timely update on its business in mid-March that it
21.2 Million Reasons Aurora Cannabis Is a Terrible Stock
If you thought the stock market has been taken on a wild ride over the past two months, then take a closer look at how marijuana stocks have fared since the beginning of April 2019. Following the
Still Waiting on Your Stimulus Check? Here's When the Next Payments Are Going Out.
COVID-19 hasn't just sickened hundreds of thousands of Americans; it's also taken a major toll on the U.S. economy. With countless businesses closed down and millions of Americans scrambling to file
If You've Got $3,000 to Invest, Buy These 3 Top Stocks Right Now
It's been more than two months since the start of the bear market that ravaged good and bad stocks alike, yet in recent weeks, the bulls have been running again as investors begin to believe that
Zoom Delivers More Security With Software Update
Zoom Video Communications (NASDAQ: ZM), the popular video conferencing app to stay connected during the COVID-19 pandemic, has beefed up its security as part of its 90-day security enhancement plan
Here's the Impact of COVID-19 on the Average American's 401(k)
When the COVID-19 pandemic sent U.S. stock markets plunging, one of the biggest worries on Americans' minds was how the crash would affect their retirement savings. Well, Fidelity just released a
Why I Just Bought This Beaten-Down Marijuana Stock
I wouldn't touch most marijuana stocks with a 10-foot pole right now. There are simply too many uncertainties, including the lingering impact of the COVID-19 pandemic. But there are few marijuana
Better Buy: Inovio Pharmaceuticals vs. GlaxoSmithKline
In one corner, we have a small and scrappy biotech that has received a lot of attention this year as its stock skyrocketed. In the other corner, there's a big pharmaceutical company that's in a
3 Dividend Stocks Yielding More Than 5% That Are Safe Buys Right Now
The higher a dividend yield is, the riskier the dividend is? This rule of thumb is applicable in many cases. Some stocks have really high dividend yields because there's an underlying problem that
Why This Hotel Stock Is Up 11% in 2020
Few industries have been hit as hard during the coronavirus pandemic as hotels, with travel basically drying up or slowing immensely for the foreseeable future.
Many of the large hotel chains have
Cresco Labs Posts 144% Revenue Growth in Q4
It's been pretty rough for Cresco Labs' (OTC: CRLBF) shareholders so far in 2020. The stock has dropped 36% year to date after plunging more than 60% at one point in March.
But investors had a
Will Last Week's Biotech IPO Outperform In a Recession?
Cancer drug developer Oric Pharmaceuticals (NASDAQ: ORIC) successfully raised $120 million in its IPO on Friday, and the stock posted a splashy opening-day gain of 61%. Here are a few reasons why
Are Stem Cells the COVID-19 Treatment We've All Been Waiting For?
Medical professionals would surely welcome any safe and effective treatment option for people with COVID-19 -- and pharmaceutical companies are doing their best to hastily find solutions


